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ABSTRACT
This study evaluated a multidisciplinary strategy to decrease the rate of invasive pulmonary
aspergillosis (IPA) among adult patients hospitalised in two haematology wards in a single 560-bed
building at the University Hospital of Saint-Etienne. Upgrading of the air filtration system and
construction of an air-lock chamber at the entrance to the unit were completed during 1994. In 1995,
specific hygienic measures were introduced during hospital building work, including the use of plastic
barriers, watering during demolition work, reduction of pedestrian traffic in construction areas, and the
wearing of high-efficiency filtration masks by immunosuppressed patients when outside the protected
unit. This strategy was evaluated by a prospective survey of IPA cases between 1993 and 2001, coupled
with environmental surveillance. The number and risk-level of hospital renovation projects increased
between 1995 and 2001 (p < 0.01). In parallel, the rate of IPA decreased globally in the haematology unit
from 0.85% (1.19 ⁄ 1000 patients) in 1993 to 0.28% (0.21 ⁄ 1000 patients) in 2001. The incidence of IPA
decreased significantly between 1993–1996 and 1997–2001 (p 0.02, Mann–Whitney test). These results
show that a multidisciplinary approach involving engineers, infection control practitioners, mycologists
and clinicians enables IPA rates among patients hospitalised in haematology wards to be significantly
decreased.
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INTRODUCTION
Fungal infections have increased in recent years
and are a major concern for hospitals, especially
in wards receiving immunocompromised pa-
tients. Among these infections, aspergillosis is
ranked second in terms of frequency, but first if
severity of infection is considered. Invasive pul-
monary aspergillosis (IPA) represents the primary
infectious cause of mortality in haematology
units, with a mortality rate as high as 70%.
Diagnosis of the disease is difficult because of the
lack of formal diagnostic criteria [1]. Therefore, it
is important to develop effective measures to
decrease the rate of hospital-acquired IPA, and
particularly to prevent the spread of the fungus
during hospital building work.
The presence of building work near hospital
wards receiving immunosuppressed patients,
e.g., haematology, transplant unit or paediatric
oncology patients, is one of the main risk-factors
for developing IPA [2,3]. At the University Hos-
pital of Saint-Etienne, France, a multidisciplinary
committee, including microbiologists, infection
control practitioners and technical engineers,
adopted a new strategy to prevent aspergillosis
in 1995. This strategy was introduced because of
an increase in building work in a one-block
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building, with concurrent episodes of IPA in
wards housing high-risk patients. The aim of the
present study was to evaluate the efficacy of this
strategy in preventing infection among patients
hospitalised in the haematology ward of the
hospital during the 7-year period from 1995 to
2001.
MATERIALS AND METHODS
Study population
The haematology department of the University Hospital of
Saint-Etienne is located in a single 560-bed building. The
department contains two wards: a four-bed ward (termed
‘very protected area’ in this study) reserved for highly
immunocompromised patients with haematological malignan-
cies, such as acute leukaemia and ⁄ or bone-marrow transplan-
tation, and a 19-bed ward (termed ‘protected area’) for other
haematological patients. All the windows were sealed against
air leaks. The ventilation system included high-efficiency
particulate air (HEPA) filters that are 99.97% efficient for
removing 0.3-lm particles, and used directed room airflow, so
that the air came from one side, flowed across the room and
exited on the opposite side, as recommended by the CDC [4].
Moreover, the department had an air-lock chamber that
maintained the air pressure at a higher level than the
surroundings. The very protected area had a decreasing
positive pressure from rooms to corridors, and an additional
HEPA filter in each room. In this ward, healthcare workers
wore gowns, masks and disposable caps. In the other ward,
standard infection control precautions were used.
Preventive hygiene measures during building work
Following an outbreak of hospital-acquired aspergillosis in the
haematology department, the air-lock chamber described
above was installed at the entrance to the haematology
department in 1994, and a preventive strategy was established
in 1995 that included the measures summarised in Table 1.
These measures were adjusted according to the type and
vicinity of hospital building work and the level of immuno-
suppression of patients. The number of patients admitted to
the haematology department was modulated according to the
extent of building work. The relocation of patients to safer
areas was considered if the safety of patients could not be
guaranteed by using the preventive measures described in
Table 1. Throughout the study period, systematic monitoring
of high-risk patients (bone-marrow transplant and severely
neutropenic patients) was performed, including Aspergillus
serology and galactomannan antigen tests twice-weekly, to
detect possible cases of IPA.
Mycological sampling and analysis
Environmental surveillance. Hospital units were ranked into
three grades according to the immunosuppression level of the
patients: (1) high-risk units, including the haematology (adult
and paediatric) units and the kidney transplantation unit; (2)
intermediate-risk units, i.e., intensive care units; and (3) low-
risk units. Following hospital building work, environmental
sampling was performed systematically in high- and medium-
risk units before reopening the unit, and also following the
occurrence of suspected cases of hospital-acquired asper-
gillosis.
Each trimester, in adult haematological wards, at least six
surface samples were taken per room in areas close to patients,
air vents and metallic surfaces (on which spores are known to
remain longer), and two air samples per room were taken in
the very protected area.
Air samples of 1 m3 were taken (AESAP1061 Impactor
Sampl’air Mk2; AES Laboratory, Bruz, France). Surface areas
of c. 10 cm2 were swabbed. These systematic samples were
taken 3 h after each room was cleaned. The environmental
surveillance results were interpreted according to regional
guidelines that define three levels, namely ‘target’, ‘alert’ and
‘action’ [5]. For air samples, the target level was 0 CFU ⁄m3,
the alert level was 1 CFU ⁄m3, and the action level was
> 1 CFU ⁄m3. For surface samples, the target level was
0 CFU ⁄ room, the alert level was 1 CFU ⁄ room for Aspergillus
fumigatus and 2 CFU ⁄ room for other filamentous fungi, and
the action level was > 1 CFU ⁄ room for Aspergillus and
> 2 CFU ⁄ room for other fungi or confirmation of the alert
level. If the alert level for air or surfaces was reached, a
second sample was taken; if the action level was reached,
corrective measures were taken, such as reviewing the
cleaning procedures, checking the ventilation system, and
transferring patients if the problem persisted.
Table 1. Preventive measures applied to decrease the risk of nosocomial aspergillosis at the University Hospital of Saint-
Etienne
General measures Additional measures during building work
Regularly inspecting air-handling systems in high-risk patient-care areas, ensuring
adequate air exchanges and pressure differentials and eliminating air leakages
Avoiding dust accumulation by supervising the cleaning of surfaces and air conducts,
and controlling the sealing of rooms containing at-risk patients
Educating HCWs on the dangers of nosocomial IPA, especially among
immunocompromised patients, and the control procedures to decrease its occurrence
Eliminating exposure of patients at high-risk for aspergillosis to potential
environmental sources of Aspergillus spp., such as contaminated food, plants
and flowers
Collecting environmental samples from potential sources by appropriate methods,
such as the use of a high-volume air sampler and swabs
Reviewing periodically the epidemiology of IPA
Organising meetings between the different disciplines to draw up guidelines
for each building project
Constructing temporary plastic barriers sealed with plastic tape between
patient-care and construction areas to prevent dust from entering
Maintaining negative air pressure at the site of building work inside the hospital
Watering during demolition work
Limiting the movement of patients and directing pedestrian traffic (workers,
patients, HCWs and visitors) in construction and patient-care areas to limit
the entrance of contaminated air
Use of high-efficiency filtration masks (PCM 2000, Kimberly Clark, Roswell GA,
USA) by immunosuppressed patients when going near building work areas
Defining a strategy for reopening a renovated at-risk unit, e.g., checking the
air filtration system, cleaning the work place and taking surface samples
for microbiological analysis
Cleaning newly constructed areas before admitting patients
HCWs, healthcare workers; IPA, invasive pulmonary aspergillosis.
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Mycological techniques. The samples were cultured on Sabou-
raud dextrose agar containing chloramphenicol (Plate Count
Agar Fungi; bioMe´rieux, Craponne, France; and Plate Count
Agar Levures Moisissures; VWR International, Strasbourg,
France). Plates used for air sampling were incubated for 1 day
at 37C to promote the growth of A. fumigatus, and were then
incubated for 4 days at 25C. Colonies were counted every
2 days. The results were expressed as CFU ⁄m3 for air samples,
and CFU ⁄ room for surface samples. Colonies were identified
to the genus level for filamentous fungi, and to the species
level for Aspergillus spp.
Definition of cases and indicators of IPA
The criteria used for IPA definition followed those defined by
Ascioglu et al. [6] in 2002:
• clinical and radiological evidence of lower respiratory tract
infection: new infiltrates on computerised tomography
imaging, e.g., halo sign, air crescent sign, or cavity within
area of consolidation (major criterion); symptoms of lower
respiratory tract infection, e.g., cough, chest pain, haemopt-
ysis, dyspnoea, physical finding of pleural rub; any new
infiltrate not fulfilling major criterion or pleural effusion
(minor criteria).
• biological criteria: positive culture or direct microscopical
evaluation for Aspergillus from sputum, bronchoalveolar
fluid samples or sinus aspirate specimen; antigen detection
in specimens of bronchoalveolar fluid or at least two blood
samples.
• host factors: neutropenia (< 500 neutrophils ⁄mm3 for
> 10 days); persistent fever for > 96 h refractory to appro-
priate broad-spectrum antibacterial treatment in high-risk
patients; body temperature either > 38C or < 36C and any
of the following predisposing conditions: prolonged
neutropenia (> 10 days) within the previous 60 days;
immunosuppressive regimen within the previous 30 days;
history of proven or probable invasive fungal infection; or
AIDS.
• histopathological criterion: identification of Aspergillus
hyphae from needle aspiration or biopsy specimen (lung,
nose, paranasal sinus, bronchi or sites of dissemination) with
evidence of associated tissue damage; or positive culture
result for a sample obtained by a sterile procedure from a
normally sterile and clinically or radiologically abnormal site
consistent with infection, excluding urine and mucous
membranes.
According to these definitions, three levels were defined
for IPA [6]: (1) proven case, with histopathological evidence
of aspergillosis; (2) probable case, with at least one host
factor criterion and one microbiological criterion, and one
major clinical criterion (or two minor clinical criteria) from
an abnormal site consistent with infection; and (3) possible
case, with at least one host factor criterion and one
microbiological or one major clinical criterion (or two minor
clinical criteria) from an abnormal site consistent with
infection. IPA was considered to be hospital-acquired if the
disease occurred > 4 days after admission [4]. As a rule, no
Aspergillus prophylaxis was prescribed for haematological
patients.
The incidence of IPA per year (I) was calculated by dividing
the number of IPA cases by the number of hospitalised
patients. The incidence density of IPA corresponded to the
number of IPA cases divided by the cumulative number of
patient-days spent in the haematology wards (ID1) or of days
of prolonged neutropenia (ID2), defined as the cumulative
number of days that the patients spent with a white blood cell
content of < 0.5 g ⁄L for patients with predictable neutropenia
of > 10 days. Data were also stratified by ward in the
haematology unit to differentiate immunosuppressed patients
from very immunosuppressed patients, such as those with
acute leukaemia or allogenic or autogenic bone-marrow
transplantation.
Mycological techniques used for diagnosis of IPA in patients
The specimens were inoculated on Sabouraud dextrose agar
containing chloramphenicol, and incubated first at 37C for
24 h to facilitate the growth of A. fumigatus, and then at 25C
for 1 week. The colonies were counted and identified on the
basis of their macroscopic and microscopic characteristics.
Serological follow-up of patients was done by the detection of
Aspergillus antigens (galactomannans) in serum using an
enzyme immunoassay (Platelia Aspergillus; Bio-Rad, Marnes
la Coquette, France). Anti-Aspergillus antibodies were detec-
ted using three different methods, namely an indirect
immunofluorescence in-house technique with antigen pre-
pared locally, an in-house ELISA technique using antigen
from Bio-Rad, and a commercially available immunoelectro-
phoresis assay (IEP Paragon; Beckman Coulter, Roissy,
France).
Evaluation of the strategy to decrease IPA
Three types of data were collected to evaluate the infection
control strategy: (1) the number and the risk-level of hospital
building works, expressed as a score [7] that takes into account
the presence of at-risk patients and the type and location of
building works (Table 2); (2) the results of environmental
surveillance, including all the samples taken systematically
after building work or investigation of suspected hospital-
acquired aspergillosis, stratified by year and Aspergillus
species; and (3) the number of cases of IPA and the annual
rate of hospital-acquired IPA (incidence and incidence density)
occurring in the haematology wards.
Statistical methods
Epi Info v.6.04 (CDC, Atlanta, GA, USA) and SPSS v.10.1 (SPSS
Inc., Chicago, IL, USA) software was used to analyse the data
by linear regression and the Mann–Whitney non-parametric
test. p values < 0.05 were considered to be significant.
Table 2. Risk-levels of hospital building work with re-
spect to the acquisition of hospital-acquired invasive
pulmonary aspergillosis [7]
Risk-level
Type and location of work with regard to the
position of the wards at risk
1 Outdoors and at a distance
2 Light renovation work indoors and on another floor
3 Outdoors and in proximity or with prevailing wind
4 Light renovation work indoors on the same floor with
isolation of the ward
Heavy renovation indoors on another floor
5 Light renovation work indoors on the same floor without
isolation of the ward
Heavy renovation work indoors on the same floor
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RESULTS
Hospital building work
As shown in Fig. 1, an overall increase in the
number of building projects was observed during
the 7-year period of the study, from 26 in 1995, to
85 in 2001. In addition, this increase was associ-
ated significantly (p < 0.001 by the Mann–Whit-
ney test) with work that had a high risk for
aspergillosis (Table 2).
Environmental surveillance
Between 1995 and 2001, 3653 environmental
samples were collected (mean ⁄ year = 609; range
171–949). As shown in Table 3, the surveillance
was based mainly on surface specimens because
of the higher sensitivity of this approach, com-
pared with air samples, for detecting low-level
contamination. The high number of samples
taken during some years was associated with
factors unrelated to hospital building work, inclu-
ding validation of an upgrading of the ventilation
system in the haematology unit during 1995,
investigation of two pseudo-outbreaks (no clinical
cases of aspergillosis) that occurred in the paedi-
atric unit during 1997, and investigations follow-
ing a steam autoclave failure in 2001. When the
Aspergillus burden was compared annually to the
number of hospital building works, no correlation
was found for A. fumigatus (r 0.49) or for other
Aspergillus spp. (r 0.09).
Rates of hospital-acquired IPA in haematology
wards
During the study period, no cases of IPA
occurred in the paediatric haematology unit. In
the kidney transplant unit, the epidemiological
data necessary to calculate the incidence indica-
tors of IPA were not available. Therefore, the
efficacy of the infection control strategy in terms
of preventing IPA was evaluated only in the
adult haematology unit. Overall, despite the
stable number of bone-marrow allografts and a
trend for an increase in autografts over time
(data not shown), the cumulative incidence (and
incidence density) of IPA cases in the haematol-
ogy wards decreased from 0.85% (1.19 ⁄ 1000 pa-
tient-days) in 1993 to 0.28% (0.21 ⁄ 1000 patient-
days) in 2001. This reduction was statistically
significant (p 0.02) when the 1993–1996 and
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Fig. 1. Number of hospital building
projects between 1995 and 2001
(Hospital Nord, University Hospital
of Saint-Etienne, France). Light grey
bars correspond to risk-levels 1–3,
and dark grey bars to risk-levels 4
and 5. Risk-levels were defined
according to the criteria listed in
Table 2.
Berthelot et al. Hygiene measures to reduce aspergillosis 741
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 738–744
1997–2001 periods were compared. Detailed
results are shown in Table 3 and Fig. 2.
Table 4 summarises the clinical and microbio-
logical characteristics of the 15 patients with IPA
in the haematology wards during the study
period. According to the criteria of Ascioglu et al.
[6] listed above, there were two proven, nine
probable and four possible cases of IPA. Except
Table 3. Results of the environmental surveillance (air and surfaces) for aspergillosis and the incidence of cases of invasive
pulmonary aspergillosis (IPA) in the adult haematology ward, Hospital Nord, University Hospital of Saint-Etienne, France
Year
Environmental surveillance Incidence of IPA cases in the adult haematology warda
Total number of samples
(% surface samples)
Number of samples containing
Aspergillus fumigatus (%)
Number of samples containing
other Aspergillus spp. (%) I (%)
ID1 (per 1000
patient- days)
ID2 (per 1000
patient- days)
1993 NA NA NA 0.85 1.19 5.39
1994 NA NA NA 0.50 0.65 2.54
1995 949 (94.9) 53 (5.6) 21 (2.2) 0.75 0.85 2.70
1996 493 (87.8) 18 (3.7) 4 (0.8) 0.79 1.21 4.70
1997 729 (95.7) 35 (4.8) 44 (6.0) 0.16 0.21 0.90
1998 171 (97.7) 26 (15.2) 13 (7.6) 0.58 0.64 1.64
1999 392 (97.7) 31 (7.9) 19 (4.8) 0.43 0.42 1.90
2000 188 (100) 18 (9.6) 13 (6.9) 0 0 0
2001 731 (92.3) 28 (3.8) 24 (3.3) 0.28 0.21 0.60
aSee Materials and methods section for the definition and mode of calculation of I, ID1 and ID2. NA, data not available.
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Fig. 2. Trends in the occurrence of
invasive pulmonary aspergillosis
(IPA) cases in the adult haematolog-
ical unit between 1992 and 2001
(University Hospital of Saint-Eti-
enne, France). Bars correspond to
the annual number of cases of IPA;
the line represents the trend in
patient-days of prolonged neutrope-
nia.
Table 4. Characteristics of documented cases of invasive pulmonary aspergillosis in the haematology unit, 1995–2001,
University Hospital of Saint-Etienne
Year Case
Haematological
disease
Pulmonary
CT scan Serology
Galactomanan
antigen in blood BAL Histopathology Outcome
Level of IPA
characterisationa
1995 1 Acute leukaemia Positive Negative Positive Negative ND Death caused by aspergillosis Probable
2 Acute leukaemia Positive Positive ND A. flavus Positive Death not caused by aspergillosis Proven
3 Acute leukaemia Positive Positive Negative ND ND Unknown Possible
4 Acute leukaemia Positive Positive ND A. fumigatus ND Unknown Probable
1996 5 Acute leukaemia Positive Negative Negative A. fumigatus ND Death not caused by aspergillosis Probable
6 Lymphoma Positive Positive Positive Negative Negative Unknown Possible
7 Cerebral lymphoma ND Negative Positive A. fumigatus ND Death caused by aspergillosis Probable
8 Lymphoma Positive Positive Positive A. fumigatus ND Unknown Probable
1997 9 Leukaemia ND Weak positive Negative A. fumigatus Negative Death caused by aspergillosis Probable
1998 10 Acute leukaemia Positive Negative Negative Negative ND Death not caused by aspergillosis Possible
11 Acute leukaemia Positive Negative Positive A. fumigatus ND Death not caused by aspergillosis Probable
12 Acute leukaemia Positive Negative Negative Negative ND Alive Possible
1999 13 Leukaemia Positiveb Positive ND A. fumigatus ND Death caused by aspergillosis Probable
14 Acute leukaemia Positive ND Positive Negative Positive Alive Proven
2001 15 Acute leukaemia Positive Positive Positive Antigen positive ND Alive Probable
CT, computerised tomography; BAL, bronchoalveolar lavage; ND, not done; IPA, invasive pulmonary aspergillosis.
aAccording to Ascioglu et al. [6].
bAssociated with cerebral aspergillosis.
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for one case involving a bone-marrow transplant
patient, all the cases involved patients with
prolonged neutropenia. The annual density inci-
dence of clinical cases of aspergillosis did not
show a correlation with the total number of
hospital building projects per year (r 0.59), or
with the number of hospital building projects per
year that were considered to be high-risk (r 0.34).
DISCUSSION
IPA is a severe disease that is associated with high
morbidity and mortality in immmunosuppressed
patients. Environmental contamination has been
associated with the occurrence of IPA among
haematological patients [8]. Of the various poss-
ible sources of Aspergillus spores, hospital build-
ing work is a major cause of the dispersal of
airborne conidia, leading to an increase in envi-
ronmental contamination [2] and to cases of
nosocomial IPA in immunocompromised patients
[9], especially if HEPA filtration is not installed in
high-risk wards [10,11].
Control measures recommended by current
guidelines [12,13] aim to decrease the rate of
IPA by reducing the exposure of immunosup-
pressed patients to Aspergillus. However, the
ability of these measures to prevent cases of IPA
is difficult to evaluate, especially in the context of
hospital building work. The objective of the
present study was to investigate the impact of a
global preventive strategy to control nosocomial
cases of IPA among haematological patients
during an intensive programme of building work.
There are several limitations concerning the inter-
pretation of the results, including the length of the
study period, the multiplicity of the preventive
measures that could have contributed to the
control strategy in the haematology wards (no-
tably, upgrading of the air filtration, construction
of an air-lock chamber, installation of barriers
during hospital building work, intensive environ-
mental surveillance, and reinforcement of the
cleaning procedures in the units), and the diffi-
culty in correlating the results of environmental
microbiological sampling with the occurrence of
IPA cases.
Despite these limitations, the present study is
one of the first to document the control of
hospital-acquired transmission of Aspergillus to
haematological patients during extensive build-
ing work. With time, the hospital building work
increased, in terms of both number of projects and
their risk-level (Fig. 1), but the environmental
Aspergillus load was essentially stable (Table 3)
and the rate of IPA decreased significantly
between 1993–1996 and 1997–2001 (p < 0.01).
These rates were low compared with those from
studies performed in other French haematology
wards (1.16 ⁄ 1000 patient-days) [13], but were
similar to those observed in a USA hospital
during a construction period [14]. Although this
decrease may have been associated initially with
an upgraded air filtration system and with the
construction of an air-lock chamber, it was more
pronounced after 1997, despite the increasing
number of hospital building projects.
Interestingly, effective control of IPA was
achieved despite an improvement in specific
diagnostic methods (including the introduction
of galactomannan antigen detection in 1995 and
the more frequent use of computerised tomogra-
phy scans to look for the halo sign) and an
absence of antifungal prophylaxis for Aspergillus.
It can be hypothesised that the control of dust
contamination during building work became
more efficient with time because of better cooper-
ation between engineers, hospital managers,
healthcare workers and the infection control team.
Another factor that may have been important was
the recommendation that immunosuppressed
patients should systematically wear a high-effi-
ciency mask when interventional procedures
were performed outside the haematology unit,
as suggested by Raad et al. [14].
This study confirmed the efficacy of institu-
tional hygiene measures [4,13,15] during hospital
building work in decreasing the occurrence of
IPA among immunosuppressed patients. Apart
from well-documented measures, such as HEPA
filtration and positive air pressure in high-risk
units, it is difficult to evaluate the individual
value of additional measures, including a require-
ment for written procedures for each building
project, construction of temporary barriers during
building work, watering of soil during demoli-
tion, maintaining negative air pressure at the site
of building work, directing pedestrian traffic in
construction areas, reinforcing the cleaning of
surfaces, performing a focused environmental
surveillance, and recommending the wearing of
high-efficiency masks by immunosuppressed pa-
tients. The results of the present study examined
the combined performance of these additional
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measures. It is important to stress the usefulness
of a multidisciplinary approach in defining and
conducting an effective preventive strategy for
aspergillosis in at-risk patients over an extended
period.
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